Evidence map›Paper›PMID 35206504›Full record

ArticleInternational journal of environmental research and public health2022

SARS-CoV-2 Seroprevalence in Healthcare Workers before the Vaccination in Poland: Evolution from the First to the Second Pandemic Outbreak.

Izabela Korona-Głowniak, Michał Mielnik, Martyna Podgajna, Ewelina Grywalska, Marek Hus, Katarzyna Matuska, Beata Wojtysiak-Duma, Dariusz Duma, Andrzej Glowniak, Anna Malm

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Transmission and Risk Factors of COVID-19 among Health Care Workers.Seminars in respiratory and critical care medicine · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Izabela Korona-GłowniakDepartment of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-1634-0387
Michał MielnikDepartment of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-081 Lublin, Poland.ORCID 0000-0003-4473-5319
Martyna PodgajnaDepartment of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-2863-5142
Ewelina GrywalskaDepartment of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-0451-4741
Marek HusDepartment of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-081 Lublin, Poland.
Katarzyna MatuskaDepartment of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, Poland.
Beata Wojtysiak-DumaDepartment of Laboratory Diagnostics, Medical University, 20-093 Lublin, Poland.
Dariusz DumaDepartment of Laboratory Diagnostics, Medical University, 20-093 Lublin, Poland.ORCID 0000-0002-5844-9033
Andrzej GlowniakDepartment of Cardiology, Medical University of Lublin, 20-093 Lublin, Poland.
Anna MalmDepartment of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-1503-7634
Medical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Healthcare workers (HCWs) are on the frontline, struggling with the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To describe recent or past infections, the serological assays enabled the assessment of the immune response developed in coronavirus disease (COVID-19) in the period when testing was hardly available. In this study, we investigated SARS-CoV-2 seroprevalence in HCWs in a Polish teaching hospital and the Regional Occupational Medicine Center after both the first and the second waves. ELISA-based tests for anti-SARS-CoV-2 IgA and IgG were used to determine immune response to SARS-CoV-2 in volunteer HCWs who worked in those institutions in May 2020 (208 participants aged 47.1 ± 12.5, 88% women) and in December 2020 (179 participants aged 45.2 ± 12.4, 86% woman). Risk factors for seropositivity were also assessed using a questionnaire filled out by all participants. We reported a significant increase in seroprevalence after the second wave (22.9%) compared with the first outbreak (2.4%) (OR 12.1; 95%CI 4.6-31.3;

Indexed as

COVID-19SARS-CoV-2AdultAntibodies, ViralFemaleHealth PersonnelHumansMaleMiddle AgedPandemicsPolandSeroepidemiologic StudiesVaccinationAntibodies, Viralhealthcare workersIgG/IgA seroprevalencerisk factorsSARS-CoV-2

Identifiers

PMID35206504
PMCPMC8871845
OpenAlexW4213077804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.